SN1
SHORT NOTE
5M
★ High-yield
Describe isoniazid with its mechanism, acetylation polymorphism, adverse effects and uses.
Pharmacology
Isoniazid (INH) is the most important antitubercular drug — cheap, potent, well tolerated and bactericidal against rapidly dividing organisms.
- A prodrug activated by the mycobacterial catalase-peroxidase KatG; the active form inhibits InhA and so the synthesis of mycolic acids, which are unique to the mycobacterial cell wall
- Resistance arises chiefly from mutation or deletion of katG (so the drug is never activated) or of the inhA promoter
- Well absorbed orally; penetrates all tissues and fluids including CSF, caseous material and macrophages
- Metabolised by acetylation, showing genetic polymorphism — about half the Indian population are slow acetylators
| Feature | Slow acetylators | Fast acetylators |
|---|---|---|
| Plasma level | Higher and more sustained | Lower |
| Peripheral neuropathy | More frequent | Less |
| Hepatitis | Less (though disputed) | More — more hydrazine metabolite is formed |
| Efficacy on daily dosing | Equivalent | Equivalent — which is why the dose is not routinely adjusted |
CLINICAL PEARL
Isoniazid causes neuropathy by competing with pyridoxine, and the remedy is therefore trivially cheap. It inhibits pyridoxine kinase and increases urinary excretion of the vitamin, producing a dose-dependent peripheral neuropathy that is entirely preventable by giving 10 to 25 mg of pyridoxine daily. In India, where malnutrition and slow acetylation are both common, this is given routinely rather than selectively.
Adverse Effects
- Peripheral neuropathy — symmetrical distal paraesthesiae and numbness; prevented by pyridoxine
- Hepatotoxicity — asymptomatic transaminase rise is common and usually settles; clinical hepatitis is uncommon but potentially fatal. Risk rises with age, alcohol, existing liver disease, pregnancy and the puerperium, and concurrent rifampicin and pyrazinamide
- CNS — insomnia, restlessness, psychosis, optic neuritis; seizures in overdose, which are refractory to conventional anticonvulsants and are treated with high-dose pyridoxine
- Lupus-like syndrome, particularly in slow acetylators
- Others — rash, fever, arthralgia, haemolysis in G6PD deficiency, pellagra-like rash from niacin deficiency
- Interactions — an enzyme inhibitor, raising phenytoin, carbamazepine and warfarin levels; with rifampicin, hepatotoxicity is increased
Uses
- Treatment of all forms of tuberculosis, always in combination
- Treatment of latent tuberculosis infection — 6 months of isoniazid alone, or 3 months of weekly isoniazid with rifapentine; used before anti-TNF therapy, in HIV, in transplant candidates and in household contacts of a sputum-positive case
- Chemoprophylaxis of children under 5 in contact with an infectious case — a core component of India’s programme, and frequently under-delivered
Applied Aspects
- Give pyridoxine routinely with isoniazid in India; the cost is trivial and the neuropathy otherwise common
- Check baseline liver function in those over 35, with alcohol use, pre-existing liver disease, HIV or pregnancy, and monitor if symptoms appear
- Tell every patient to stop the drug and report immediately if they develop nausea, vomiting, abdominal pain, jaundice or dark urine
- Isoniazid overdose causes the triad of refractory seizures, metabolic acidosis and coma, and is treated with gram-for-gram pyridoxine — a diagnosis worth recognising, since it is easily mistaken for other causes of status epilepticus
- Latent tuberculosis treatment is one of the weakest links in tuberculosis control in India; contact tracing and preventive therapy prevent far more disease than treating cases alone
All questions in Antimicrobials: TB, Fungal, Viral & Antiparasitic
- Q1Classify antitubercular drugs. Describe the first-line drugs with their mechanisms and adverse effects, the standard regimens and drug-resistant tuberculosis. ★
- Q2Classify antimalarial drugs by stage of action. Describe chloroquine, the artemisinins and the other agents. ★
- Q3Classify antifungal drugs. Describe amphotericin B and the azoles with their uses and adverse effects. ★
- Q4Describe the antiviral drugs and the principles of antiretroviral therapy. ★
- Q5Classify anthelmintic drugs. Describe the antiamoebic drugs and the treatment of visceral leishmaniasis. ★
- SN1Describe isoniazid with its mechanism, acetylation polymorphism, adverse effects and uses. ★
- SN2Describe rifampicin with its mechanism, uses, adverse effects and interactions. ★
- SN3Describe the antileprotic drugs and WHO multidrug therapy. Add a note on lepra reactions. ★
- SN4Describe chloroquine with its mechanism, uses, adverse effects and resistance. ★
- SN5Explain the rationale for artemisinin-based combination therapy and describe the regimens used in India. ★
- SN6Describe amphotericin B with its mechanism, formulations, uses and toxicity. ★
- SN7Describe the drugs used in visceral leishmaniasis and the basis of the elimination programme in India.